Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yumiko Oka is active.

Publication


Featured researches published by Yumiko Oka.


The FASEB Journal | 2003

Epimorphin acts to induce hair follicle anagen in C57BL/6 mice

Kyoko Takebe; Yumiko Oka; Derek C. Radisky; Hokari Tsuda; Keiko Tochigui; Shogo Koshida; Katsuyuki Kogo; Yohei Hirai

Epimorphin is a mesenchymal morphogen that has been shown to mediate epithelial‐mesenchymal signaling interactions in various organs. We now show that epimorphin functions in hair follicle morphogenesis; using a novel ex vivo organ culture assay, we define a mechanism for epimorphin signaling that may provide insight into general developmental processes. We found that epimorphin was produced by follicular mesenchymal cells and bound selectively to follicular epithelial cells, and that treatment with recombinant epimorphin could stimulate procession of hair follicles from telogen (resting stage) to anagen (growing stage). Based on analyses of epimorphin proteolytic digests that suggested a smaller peptide might be able to substitute for the full‐length epimorphin molecule, we determined that pep7, a 10‐amino acid peptide, was capable of inducing telogen‐to‐anagen transition both in the culture assay and in the mouse. That pep7 showed maximal activity only when modified with specific sulfhydryl‐reactive reagents suggested that a particular structural conformation of the peptide was essential for activity; molecular dynamics studies were pursued to investigate the active peptide structure. These findings define a previously unknown morphogenic process in the hair follicle that may have applications to many other organs.—Takebe, K., Oka, Y., Radisky, D., Tsuda, H., Tochigui, K., Koshida, S., Kogo, K., Hirai, Y. Epimorphin acts to induce hair follicle anagen in C57BL/6 mice. FASEB J. 17, 2037–2047 (2003)


European Journal of Vascular and Endovascular Surgery | 1995

An infection-resistant PTFE vascular graft; spiral coiling of the graft with ofloxacin-bonded PTFE thread

Kazuhiro Okahara; Jun-ichi Kambayashi; Takashi Shibuya; Tomio Kawasaki; M. Sakon; Y. Dohi; Yumiko Oka; Shigehiko Ito; Shinichi Miyake

OBJECTIVE To develop an infection-resistant polytetrafluoroethylene (PTFE) vascular graft for potential clinical use in grafting in sites of bacterial contamination and in replacement of the infected grafts. SETTING Experimental study in rabbits. MATERIALS AND METHODS An antibiotic ofloxacin (OFLX) was bonded to a sheet of PTFE by impregnation, which was cut and twisted into fine threads. The in-vitro antibacterial activity of OFLX-PTFE thread was determined by measuring the zone of growth inhibition against Escherichia coli. The thread was spirally coiled around a ridged outerwall PTFE to make the OFLX-PTFE graft. OFLX-PTFE graft or control graft was interposed in the inferior vena cava (IVC) of rabbits and the entire graft was covered with fibrin containing a fixed number of E. coli. Three or 7 days after the grafting, the grafts with perigraft tissue were harvested and subjected to bacteriological studies. RESULTS In spite of early phase rapid elution of OFLX, a significant antibacterial activity was retained for more than 2 weeks. The antibacterial activity of OFLX-PTFE threads implanted in the subcutaneous space of rabbits decreased to 48% after 24 h and to approximately 1% after a week. The swab culture of all the control grafts was positive, while only one of 13 PTFE-OFLX grafts was positive. The number of viable bacteria in the perigraft tissue of OFLX-PTFE grafts was remarkably low in comparison with that of control grafts. Thus, the OFLX-PTFE grafts exhibited a marked in-vivo antibacterial activity. CONCLUSION By a unique method, it was possible to furnish PTFE graft with an excellent infection-resistant property, without affecting the original biological behaviour.


Archive | 1994

Antibacterial vascular prosthesis and surgical suture

Shinichi Miyake; Shigehiko Ito; Yumiko Oka; Jun-ichi Kambayashi; Kazuhiro Okahara


Journal of Cell Biology | 2001

Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta.

Yohei Hirai; Derek C. Radisky; Rosanne Boudreau; Marina Simian; Mary E. Stevens; Yumiko Oka; Kyoko Takebe; Shin-ichiro Niwa; Mina J. Bissell


Experimental Cell Research | 1996

Inductive influences of epimorphin on endothelial cells in vitro.

Yumiko Oka; Yohei Hirai


Archive | 2002

Oligopeptides for promoting hair growth

Yohei Hirai; Yumiko Oka; Kyoko Takebe; Hokari Tsuda; Keiko Tochigi; Toko Shinagawa; Kayoko Murakami; Shogo Koshida


Archive | 1993

Human Id genes

Kinichiro Oda; Susumu Nakada; Eiji Hara; Tomoko Yamaguchi; Takeshi Nakamura; Yumiko Oka; Toshihiko Kishimoto


Stella | 2000

A・ビュイジーヌ『ヴェルレーヌ』

由美子 岡; Yumiko Oka; ユミコ オカ


Stella | 1998

ヴェルレーヌ・サチュルニアン : 処女詩集のタイトルをめぐって

由美子 岡; Yumiko Oka


Archive | 1995

Modifiziertes Epimorphin Modified Epimorphin

Yohei Hirai; Shogo Koshida; Yumiko Oka

Collaboration


Dive into the Yumiko Oka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shigehiko Ito

Sumitomo Electric Industries

View shared research outputs
Top Co-Authors

Avatar

Shinichi Miyake

Sumitomo Electric Industries

View shared research outputs
Top Co-Authors

Avatar

Yohei Hirai

Kwansei Gakuin University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kyoko Takebe

Sumitomo Electric Industries

View shared research outputs
Top Co-Authors

Avatar

Shogo Koshida

Sumitomo Electric Industries

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eiji Hara

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hokari Tsuda

Sumitomo Electric Industries

View shared research outputs
Researchain Logo
Decentralizing Knowledge